As both reduced renal function and elevated urinary albumin or protein are independently associated with adverse kidney outcomes (end-stage renal disease, AKI and progression of CKD)1 as well as cardiovascular events in the general population, monitoring may be warranted . The gene discussed is ALB; the disease is chronic kidney disease.